Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$3.8B
183M shares
52-week range
$17.15 – $76.51
6% from low
Sector
SERVICES-COMPUTER PROGRAMMING SERVICES
Exchange
NYSE
CS
Borrow rate
0.40%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $85.7M | $116.4M | $206.9M | $343.5M | $419.1M | $475.4M | $570.4M | $644.9M |
| Cost of revenue | $10.9M | $14.9M | $31.2M | $39.8M | $53.5M | $50.7M | $55.9M | $70.3M |
| Gross profit | $74.8M | $101.5M | $175.7M | $303.8M | $365.6M | $424.8M | $514.5M | $574.5M |
| Gross margin | 87.3% | 87.2% | 84.9% | 88.4% | 87.2% | 89.3% | 90.2% | 89.1% |
| R&D | $27.5M | $32.4M | $43.9M | $62.4M | $80.2M | $82.0M | $93.0M | $130.7M |
| Operating income | $6.9M | $22.2M | $53.3M | $113.5M | $125.1M | $163.9M | $227.8M | $214.9M |
| EBITDA | $7.5M | $23.1M | $57.0M | $119.0M | $143.4M | $182.1M | $240.8M | $264.4M |
| Net income | $7.8M | $29.7M | $50.2M | $154.8M | $112.8M | $147.6M | $223.2M | $196.1M |
| Net margin | 9.1% | 25.5% | 24.3% | 45.1% | 26.9% | 31.0% | 39.1% | 30.4% |
| EPS (diluted) | 0.00 | 0.06 | 0.12 | 0.70 | 0.53 | 0.72 | 1.11 | 0.98 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $670M | $1.43 | $1.29–$1.56 | 12 |
| 2028 | $715M | $1.59 | $1.24–$1.70 | 9 |
| 2029 | $769M | $1.86 | $1.82–$1.92 | 2 |
| 2030 | $798M | $2.01 | $1.96–$2.07 | 1 |
Forward consensus · source: Financial Modeling Prep
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
www.doximity.comNo one on the platform currently holds DOCS.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 3,059,749 | $71.3M |
| Bridgewater Associatesas of 2026-03-31 | 120,019 | $2.8M |
No one on the platform has traded DOCS yet.
| $19.9B |
| — |
| HQYHealthEquity, Inc. | $90.00 | +2.49% | $7.5B | — |
| ICLRICON Public Limited Company | $171.67 | -0.76% | $13.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 18.8× earnings vs its 54.7× historical median P/E.
Fair value ≈ $60.73 · price $20.87 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Pre-Market Fly By for Monday, June 29th: Breaking Stock Market News $CMCSA $DOCS $IRDM $MLM
View on StockTwits ↗$DOCS https://anachart.com/wp-content/uploads/2026/06/1782730873_soc-img.jpg
View on StockTwits ↗$DOCS If you bought $DOCS there's still time to file a claim before the settlement deadline on July 16. If you bought shares between 2021 and 2023, you may be eligible. The case claimed Doximity misled investors about its business performance and growth metrics. After a research report raised concerns about declining sales, executive departures, and questionable KPIs, $DOCS fell more than 4%, wiping out over $135 million in market value. You can check it out and file your claim before the deadline: https://11th.com/cases/doximity-investor-suit
View on StockTwits ↗Reminder: $DOCS $31M investor settlement deadline is July 16, 2026. Investors who bought between June 24, 2021 through August 8, 2023 qualify. Doximity allegedly misled investors about its advertising business strength. A critical report in April 2024 revealed executive departures, accounting concerns, and rising competition, causing shares to drop and lawsuits to follow. In 2025, a $31M settlement was reached. File your claim before July 16, 2026: https://11th.com/cases/doximity-investor-suit
View on StockTwits ↗$DOCS Outstanding article that hits the mark on DOCS's current state. So if you want to refresh your DOCS insights or learn about DOCS from scratch, this is a must read. https://everyticker.com/quote/DOCS/analysis/doximity-s-ai-pivot-a-3-6b-physician-network-betting-its-margins-on-the-third-act-nyse-docs
View on StockTwits ↗$DOCS Share Price: $20.69 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $3.65 – $4.51 Target Zone: $6.94 – $8.48 Potential Upside: 79% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$DOCS - Deadline reminder for Doximity investors. A $31 million settlement is currently accepting claims for investors who purchased Doximity ($DOCS) shares between June 24, 2021, and August 8, 2023. The deadline to submit a claim is July 16, 2026. The lawsuit claimed the company misled investors about user activity and engagement on its platform. When growth concerns and weaker guidance became public, the stock sold off and investors filed suit. If you held $DOCS during that period, now may be a good time to check your eligibility before the filing window closes: https://11th.com/cases/doximity-investor-suit
View on StockTwits ↗$DOCS investors — there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/doximity-investor-suit
View on StockTwits ↗$DOCS - Doximity Inc - 10K - Updated Risk Factors 🚨 Peer Alert: Risk-factor words are +43.1% above peer average (25,125 vs 17,559 across 429 peers). DOCS flags rising exposure to AI-related operational, legal, and regulatory risks, heavier dependence on rapidly evolving AI and tech infrastructure (including third-party models), concentrated customer revenue, management turnover, and mounting litigation that could hit cash flow, reputation, and competitiveness. #HealthcareTechnology #ArtificialIntelligenceRisks #RegulatoryCompliance #CustomerConcentration #LitigationExposure 🟢 Added 🟠 Removed https://d-risk.ai/DOCS/10-K/2026-05-19
View on StockTwits ↗$DOCS i bought this today ....can someone please tell me that im not a idiot for buying this ?....
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-5-19-dr-martens-plc-stock-1/ $DOCS Dr. Martens Earnings Transcript
View on StockTwits ↗https://marketbeat.com/a/8662620/ $DOCS Dr. Martens H2 Earnings Call Highlights
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.